Azzur Group Wins Best Early-Phase BioTech Manufacturing Firm & Innovation Excellence Awards
April 23, 2024
Global Health & Pharma (GHP) Magazine announced the winners of the Biotechnology Awards 2024, naming Azzur Group as the Best Early-Phase Biotech Manufacturing Firm - North America and the GHP Innovation Excellence Award recipient.
“More than 3,000 advanced therapies and treatments are already in the global pipeline. Azzur’s new ATMP holistic, platform service encapsulates manufacturing infrastructure, expertise, and testing capability that meets the continuum of demand across the development to commercial lifecycle. This model ensures risk mitigation, flexibility, and absolute IP protection for innovators within fit for phase and scale infrastructure.” - Sarah Stevens, President of Azzur Labs & Azzur Cleanrooms on Demand™ at Azzur Group
Read the full article and list of winners published in GHP's 2024 Biotechnology Awards issue to learn more about how Azzur Group offers GMP (good manufacturing practice) solutions From Discovery to Delivery™. GHP Magazine, with a circulation of 110,000 global readers, provides the latest innovations and advancements within the pharmaceutical and healthcare industries.